cast Bioshield was signed in July p...

cast Bioshield was signed in July providing $56 billion above the next 10 years for stockpiling of vaccines and mix with drugss to fight anthrax, smallpox, and other biological agents. Additionally, the law gives FDA authority to distribute promising of recent origin drugs and antidotes in an conjuncture NIH will launch initiatives to spe progress to maturity of new treatments for victims of biological, radiological, and nuclear attacks.

However, while the legislation proffers new opportunities, some companies report the legislation does not do enough to screen companies if a medicine has adverse effects or